This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

Find out more here.

ENact-PD: EEG Neuro-feedback in Parkinson's. Version1.0

  • Research type

    Research Study

  • Full title

    ENact-PD: EEG Neurofeedback to improve motor symptoms in Parkinson's: A feasibility trial of alpha frequency neuro-feedback in alleviating motor symptoms in Parkinson’s disease

  • IRAS ID

    195863

  • Contact name

    John Vincent Hindle

  • Contact email

    j.v.hindle@bangor.ac.uk

  • Sponsor organisation

    Betsi Cadwaladr University Health Board

  • ISRCTN Number

    ISRCTN16783092

  • Duration of Study in the UK

    1 years, 6 months, 30 days

  • Research summary

    This is a feasibility study to assess and determine the practicalities of, usability of and patient receptiveness to use of EEG based Neurofeedback as a mode of non-pharmacological symptom alleviation in Parkinson’s disease (PD). It is our early hypothesis that EEG based neuro-feedback for patients with PD can measurably improve motor function. This work would provide a pathway to portfolio for design of a full national multi-centre trial of EEG neuro-feedback in PD. The project fits with the top ten research priorities of Parkinson’s UK, in particular the themes of improving dexterity and individualised treatments. The aim is to submit a full project grant application to Parkinson’s UK for a multicentre trial based on the results of this feasibility study. The research team draws on multi-disciplinary expertise across the clinical-medical, psychological, sociological and neurosciences research fields and builds on well-established national collaboration and the growing strengths of BCUHB and Bangor University in research on non-pharmacological treatments for PD.

  • REC name

    Wales REC 4

  • REC reference

    16/WA/0115

  • Date of REC Opinion

    6 May 2016

  • REC opinion

    Favourable Opinion